Opoc, John Mark A.

HRN: 22-75-31  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2023
CEFUROXIME 750MG (VIAL)
03/17/2023
03/23/2023
IV
670mg
Q8
Pcap C
Waiting Final Action 
03/26/2023
CLINDAMYCIN 300MG (CAP)
03/26/2023
04/02/2023
PO
300
TID
PCAP C; TB Presumptive; Scrofuloderma
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: